Skip to content

How to get more sclerotherapy patients: a plan for practices

A front desk team member at a med spa and aesthetic clinic handles a new patient call

Sclerotherapy for spider veins on the legs is often a cash-pay treatment, and the drug labels say a lot about how it should be described. This guide is for practice owners, patient coordinators and front desk teams: what the FDA-approved labeling covers, which claims to avoid, and how to answer first calls so requests turn into booked consultations.

  1. SearchAn adult looks for care near them.
  2. Your pageWhat you treat, who sees them, one way to book.
  3. Call or formThey call or send a request.
  4. Front deskBooks the visit and never guesses a cause.
  5. Clinical teamThe clinician decides the plan.
How a new patient request reaches your practice.

1. Know what the approved drugs are for

Asclera (polidocanol) was approved by FDA in 2010. Its prescribing information says it is indicated “to sclerose uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity”, and that it “has not been studied in varicose veins more than 3 mm in diameter”. The label uses the 0.5% strength for spider veins and the 1% strength for reticular veins.

Sodium tetradecyl sulfate, another sclerosing agent, is labeled for “small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves”.

  • Describe the service as treatment for spider veins and small reticular veins on the legs, and say which product your clinicians use.
  • Large, bulging or painful veins are a different conversation. Say that a clinician will evaluate them, rather than offering the same cosmetic package.
  • These are drugs, so “FDA approved” is the right term for the product. Do not stretch it to the whole treatment or to uses outside the label; see FDA approved vs FDA cleared.

2. Keep claims in line with the label

The label gives practices concrete facts to work with:

  • “Repeat treatments may be necessary” when more than 10 mL is needed, and these “should be separated by 1 to 2 weeks”.
  • After treatment, the label calls for compression with a stocking or bandage, a 15 to 20 minute walk, and observation for allergic reactions. Patients are advised to wear compression stockings or support hose “continuously for 2 to 3 days and for 2 to 3 weeks during the daytime”.
  • For two to three days, patients are advised to avoid “heavy exercise, sunbathing, long plane flights, and hot baths or sauna”.
  • The most common reactions in the main study were at the injection site: bruising (haematoma), irritation, discoloration, pain and itching. Skin hyperpigmentation is listed among post-marketing reports.
  • Warnings include anaphylaxis, venous thrombosis and pulmonary embolism, arterial embolism, and tissue necrosis.

So avoid “one session”, “no downtime”, “permanent”, “painless”, “no side effects” and “risk-free”. Better wording: “treatment is done in one or more sessions”, “you will wear compression stockings afterwards” and “your clinician will explain the risks and aftercare”. Do not promise that veins will disappear or that new ones will not appear.

3. Answer first-call questions honestly

  • How much does it cost? Give a clear price per session and say what it includes (the consultation, the session, follow-up). Since more than one session may be needed, say so up front rather than quoting a single-session price as the total.
  • How many sessions will I need? “It depends on how many veins you have and how they respond. The clinician will give you a plan at the consultation.”
  • Is there downtime? “You walk for a short while right after treatment, then you will wear compression stockings and avoid heavy exercise, sunbathing, long flights and hot baths for a few days.”
  • Can I have it while pregnant? “Please tell the clinician; they will advise you.” The label notes “minimal benefit” in treating these veins during pregnancy, as veins that appear then “may spontaneously regress postpartum”.

Leave medical screening to the clinician. The label says people with reduced mobility, a history of deep vein thrombosis or pulmonary embolism, recent major surgery, a long hospital stay or pregnancy are at higher risk of thrombosis, so your intake form should ask about these and the clinician decides. Use the new patient phone script for the rest of the call.

4. Plan bookings around aftercare

Because of the compression stockings and a few days without sunbathing, long flights or hard workouts, some patients may prefer to schedule around trips, events and summer. Mention aftercare when you book, and offer times that leave room for a series of sessions 1 to 2 weeks apart when the clinician plans more than one.

5. Price, package and follow up

Where MediLeadGen fits

MediLeadGen sends practices requests from people interested in cash-pay elective treatments. Each request goes to one practice only, with the person’s consent naming that practice, at a fixed price per delivered request.

See how it works for practices

Questions practices ask

How do we get more sclerotherapy patients?

Answer requests quickly, give a clear price per session and say more than one may be needed, explain the compression stockings and aftercare honestly, keep claims in line with the drug label, and book a consultation where the clinician can plan treatment.

What is Asclera approved for?

Its label says it is indicated to sclerose uncomplicated spider veins (1 mm or less) and uncomplicated reticular veins (1 to 3 mm) in the lower extremity. It has not been studied in varicose veins larger than 3 mm.

Can we advertise sclerotherapy as having no downtime?

Avoid it. The label advises compression stockings continuously for 2 to 3 days and during the day for 2 to 3 weeks, and avoiding heavy exercise, sunbathing, long flights and hot baths for two to three days.

Is sclerotherapy one session?

Not always. The label says repeat treatments may be necessary, separated by 1 to 2 weeks, so quote prices per session and let the clinician set the plan.

General information for practice teams, not legal or clinical advice. Check the labeling of the products you use, state rules and your advertising with counsel and your clinicians. Last reviewed October 2026.

More resources

All resources for practices